Advocacy Actions
Comments on CFDA's Announcement 52, 53, 54, 55 on Encouraging Innovation in Pharmaceutical and Medical Devices
European Chamber Pharmaceutical Working Group submitted comments on CFDA's Announcement No. 52, 53, 54, 55 on encouraging innovation in pharmaceutical and medical device.
Read moreMeeting with Vice-Governor of Anhui Province on Healthcare Industry
European Chamber Pharmaceutical Working Group representatives met with Mr. Xie Guangxiang, Vice-Governor of Anhui Province on healthcare industry and healthcare reform.
Read moreComments on MEP's Administrative Regulations on Access to and Benefits Sharing on Biological Genetic Resources (Draft for Comments)
European Chamber Comments on MEP's Administrative Regulations on Access to and Benefits Sharing on Biological Genetic Resources (Draft for Comments)
Read moreComments on Anti-unfair Competition Law (Draft Revision)
The European Chamber submitted consolidated comments from member companies to the National People's Congress on Anti-unfair Competition Law (Draft Revision).
Read moreSpeech at the 2017 International Pharmaceutical Innovation Forum in Nanjing
European Chamber Secretary General Mr. Adam Dunnett gave a keynote speech at 2017 International Pharmaceutical Innovation Forum in Nanjing, raising European businesses' recommendations on promoting innovation in China
Read moreLobby Letter to Department of Market Order, MOFCOM, on Two-Invoice Policy
European Chamber Pharmaceutical Working Group issued a lobby letter to the Department of Market Order, MOFCOM, on suggestions on the Two-Invoice Policy.
Read moreLobby Letter to CFDA on Drug Renaming and Impact on Reimbursement
Lobby Letter to CFDA on Drug Renaming and Impact on Reimbursement
Read moreMeeting with DDG of Anhui Department of Commerce
European Chamber Shanghai Pharmaceutical Working Group delegation met with DDG of Anhui Department of Commerce
Read moreMeeting with Zhang Zhikuan, Director General of BFDA, to discuss regulatory processes
Meeting of the European Chamber with Mr. Zhang Zhikuan, Director General of the Beijing Food and Drug Administration
Read more